83 related articles for article (PubMed ID: 29022644)
1. Assessment of risk factors in metastatic/recurrent tall cell variant of papillary thyroid carcinoma.
Okuyucu K; Alagoz E; Ince S; Arslan N
Endokrynol Pol; 2017; 68(6):623-630. PubMed ID: 29022644
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors Associated With Recurrence and Death in Patients With Tall Cell Papillary Thyroid Cancer: A Single-Institution Cohort Study With Predictive Nomogram.
Wu SS; Joshi N; Sharrett J; Rao S; Shah A; Scharpf J; Burkey B; Lamarre ED; Prendes B; Siperstein A; Shin J; Berber E; Jin J; Krishnamurthi V; Nasr C; Hong L; Buchberger DS; Woody N; Koyfman SA; Geiger JL
JAMA Otolaryngol Head Neck Surg; 2023 Jan; 149(1):79-86. PubMed ID: 36454559
[TBL] [Abstract][Full Text] [Related]
3. Papillary thyroid carcinoma tall cell subtype (PTC-TC) and high-grade differentiated thyroid carcinoma tall cell phenotype (HGDTC-TC) have different clinical behaviour: a retrospective study of 1456 patients.
Ghossein R; Katabi N; Dogan S; Shaha AR; Tuttle RM; Fagin JA; Ganly I; Xu B
Histopathology; 2024 Jun; 84(7):1130-1138. PubMed ID: 38528726
[TBL] [Abstract][Full Text] [Related]
4. Diffuse Sclerosing Papillary Thyroid Carcinoma: Clinicopathological Characteristics and Prognostic Implications Compared with Classic and Tall Cell Papillary Thyroid Cancer.
Scholfield DW; Fitzgerald CW; Alzumaili B; Eagan A; Xu B; Martinez G; Tuttle RM; Shaha AR; Shah JP; Wong RJ; Patel SG; Ghossein RA; Ganly I
Ann Surg Oncol; 2023 Aug; 30(8):4761-4770. PubMed ID: 37154968
[TBL] [Abstract][Full Text] [Related]
5. Thyroglobulin as a Rapid and Cost-Effective Biomarker for Diagnosis of Thyroid Carcinoma Brain Metastasis: A Case Report of a Patient with Metastatic Hurthle Cell Thyroid Carcinoma.
Ntotsikas K; Lazarioti S; Daraki V; Drakos E; Tsakalomatis PN; Syntzanaki EK; Moustakis N; Marinis AI; Salapatas-Gkinis A; Xekouki P; Vakis A; Tsitsipanis C
Am J Case Rep; 2023 Oct; 24():e939025. PubMed ID: 37853680
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic clues indicating tall cell variants of papillary thyroid carcinoma in fine needle aspiration.
Tanaka A; Hirokawa M; Higuchi M; Suzuki A; Yamao N; Hayashi T; Kuma S; Miyauchi A
Diagn Cytopathol; 2019 May; 47(5):452-457. PubMed ID: 30582297
[TBL] [Abstract][Full Text] [Related]
7. Combined analysis of circulating epithelial cells and serum thyroglobulin for distinguishing disease status of the patients with papillary thyroid carcinoma.
Lin HC; Liou MJ; Hsu HL; Hsieh JC; Chen YA; Tseng CP; Lin JD
Oncotarget; 2016 Mar; 7(13):17242-53. PubMed ID: 26684026
[TBL] [Abstract][Full Text] [Related]
8. The rising trend in papillary thyroid carcinoma. True increase or over diagnosis?
Hajeer MH; Awad HA; Abdullah NI; Almuhaisen GH; Abudalu LE
Saudi Med J; 2018 Feb; 39(2):147-153. PubMed ID: 29436563
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic and Prognostic Features of Pediatric Follicular Cell-derived Thyroid Carcinomas: A Retrospective Study of 222 Patients.
Saliba M; Alzumaili BA; Katabi N; Dogan S; Tuttle RM; Zoltan A; Pandit-Taskar N; Xu B; Ghossein RA
Am J Surg Pathol; 2022 Dec; 46(12):1659-1669. PubMed ID: 36040037
[TBL] [Abstract][Full Text] [Related]
10. Subclassification of non-solid-type papillary thyroid carcinoma identification of high-risk group in common type.
Bai Y; Kakudo K; Li Y; Liu Z; Ozaki T; Ito Y; Kihara M; Miyauchi A
Cancer Sci; 2008 Oct; 99(10):1908-15. PubMed ID: 19016749
[TBL] [Abstract][Full Text] [Related]
11. PDGFRα Regulates Follicular Cell Differentiation Driving Treatment Resistance and Disease Recurrence in Papillary Thyroid Cancer.
Lopez-Campistrous A; Adewuyi EE; Benesch MGK; Ko YM; Lai R; Thiesen A; Dewald J; Wang P; Chu K; Ghosh S; Williams DC; Vos LJ; Brindley DN; McMullen TPW
EBioMedicine; 2016 Oct; 12():86-97. PubMed ID: 27682510
[TBL] [Abstract][Full Text] [Related]
12. A Critical Assessment of Diagnostic Criteria for the Tall Cell Subtype of Papillary Thyroid Carcinoma-How Much? How Tall? And When Is It Relevant?
Turchini J; Fuchs TL; Chou A; Sioson L; Clarkson A; Sheen A; Delbridge L; Glover A; Sywak M; Sidhu S; Gill AJ
Endocr Pathol; 2023 Dec; 34(4):461-470. PubMed ID: 37864666
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and immune checkpoint status of radioiodine-refractory recurrent papillary thyroid carcinomas from Ukrainian Chornobyl Tissue Bank donors.
Bogdanova T; Rogounovitch TI; Zurnadzhy L; Mitsutake N; Tronko M; Ito M; Bolgov M; Chernyshov S; Gulevatyi S; Masiuk S; Yamashita S; Saenko VA
Front Endocrinol (Lausanne); 2023; 14():1343848. PubMed ID: 38260161
[TBL] [Abstract][Full Text] [Related]
14. Diffuse sclerosing variant papillary thyroid carcinoma has worse survival than classic papillary thyroid carcinoma: a meta-analysis.
Crayton H; Wu K; Leong D; Bhimani N; Gild M; Glover A
Endocr Relat Cancer; 2023 Jun; 30(6):. PubMed ID: 36952650
[TBL] [Abstract][Full Text] [Related]
15. Management of pediatric papillary thyroid cancer.
Pazaitou-Panayiotou K
Hell J Nucl Med; 2023; 26 Suppl():60-64. PubMed ID: 37658567
[TBL] [Abstract][Full Text] [Related]
16. Modeling Thyroid Cancer Epidemiology in the United States Using Papillary Thyroid Carcinoma Microsimulation Model.
Alagoz O; Zhang Y; Arroyo N; Fernandes-Taylor S; Yang DY; Krebsbach C; Venkatesh M; Hsiao V; Davies L; Francis DO
Value Health; 2024 Mar; 27(3):367-375. PubMed ID: 38141816
[TBL] [Abstract][Full Text] [Related]
17. The Prognostic Power of Preablation Stimulated Thyroglobulin in Children With Differentiated Thyroid Cancer.
Nesari Javan F; Askari E; Shafiei S; Roshanravan V; Aghaei A; Ayati N; Zakavi SR
Endocr Pract; 2024 Mar; 30(3):209-217. PubMed ID: 38092290
[TBL] [Abstract][Full Text] [Related]
18. The expression of two immunosuppressive SIGLEC family molecules in papillary thyroid cancer and their effect on prognosis.
Jin T; Wang W; Ge L; Li X; Ge M
Endocrine; 2023 Dec; 82(3):590-601. PubMed ID: 37480496
[TBL] [Abstract][Full Text] [Related]
19. Incidence of Clinically Relevant Thyroid Cancers Remains Stable for Almost a Century: A Population-Based Study.
Genere N; El Kawkgi OM; Giblon RE; Vaccarella S; Morris JC; Hay ID; Brito JP
Mayo Clin Proc; 2021 Nov; 96(11):2823-2830. PubMed ID: 34736609
[TBL] [Abstract][Full Text] [Related]
20. Overall survival of patients with thyroid cancer in Martinique (2008-2018).
Lin L; Almont T; Beaubrun M; Macni J; Pierre-Louis A; Zabulon A; Draganescu C; Lin L; Sabbah N; Drame M; Veronique-Baudin J; Joachim C
BMC Cancer; 2023 Aug; 23(1):739. PubMed ID: 37563603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
